Articles
20.05.2021
What is HST

NICE’s Highly-Specialised Technologies (HST) process is a method for evaluating medicines and trea...

Read more
News
19.05.2021
PMA Insights Week 23

We summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...

Read more
Articles
12.05.2021
NICE 5-year strategy

NICE has set out its plan using four key pillars designed to elicit incremental change within the UK...

Read more
Articles
11.05.2021
Market access training for speciality products

Securing patient access in specialty products is becoming increasingly challenging due to the comple...

Read more
Articles
12.04.2021
Benefits of early dialogue with HTA

Remap Consulting has significant expertise in guiding companies through both EUnetHTA / EMA Parallel...

Read more
Articles
31.03.2021
Recent changes to Italian P&R

Within the last few months, the significant changes proposed to the Italian pricing and reimbursemen...

Read more
Articles
29.03.2021
What is Relative Effectiveness Assessment

Relative Effectiveness Assessment (REA) is a type of assessment that evaluates the effectiveness of ...

Read more
Articles
15.03.2021
Identifying market access challenges

Interactive eLearning is a fantastic way of engaging with small to large scale audiences that can be...

Read more
News
11.03.2021
Asia Pacific Digital Health Insights

Remap Consulting recently attended an ISPOR webinar discussing the digital health ecosystem in APAC ...

Read more
Articles
01.03.2021
NRDL expansions

China has the second largest healthcare system in the world. However, this market has been challengi...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.